News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH
Photo of Benedikt Westphalen taken from LinkedIn
Dec 16, 2024, 08:08

Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared some insights from an article by Jonathan D. Schoenfeld et al. on X:

“In Clinical Cancer Research – new data from NCI MATCH:

Arm Z1D highlights new biomarkers in non-colorectal dMMR tumors: NGS-based MSI and immune infiltration predict response to PD-1 blockade with nivolumab.”

Next generation sequencing-based MSI scoring predict benefit in mismatch repair deficient tumors treated with nivolumab: follow-up on NCI-MATCH arm Z1D

Authors: Jonathan D. Schoenfeld, Nilofer S. Azad, Jacob Gross, Li Chen, Michael J. Overman, Katrina Kao, Latifa F. Jackson, Donna Brunnquell, Xiangning Bu, Christina Coppola, Ping Guan, Jennifer Lee, David Sims, Rebecca Fuchs, Jason L. Weirather, Kathleen L. Pfaff, Lauren Gunasti, Srin Ranasinghe, Stanley R. Hamilton, Victoria Wang, Peter J. O’Dwyer, Catherine J. Wu, Scott J. Rodig, David R. Patton, Lyndsay Harris

Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH

Ben Westphalen biomarkers Cancer research Catherine J. Wu CCR AACR Christina Coppola David R. Patton David Sims dMMR tumors Donna Brunnquell genetic data Immune Infiltration Jacob Gross Jason L. Weirather Jennifer Lee Jonathan D. Schoenfeld Kathleen L Pfaff Katrina Kao Latifa F. Jackson Lauren Gunasti Li Chen Lyndsay Harris Michael J. Overman NCI MATCH NGS-based MSI Nilofer S. Azad nivolumab non-colorectal tumors OncoDaily Oncology oncology research PD-1 blockade Peter J. O’Dwyer Ping Guan Precision Medicine Rebecca Fuchs Scott J Rodig Srin Ranasinghe Stanley R. Hamilton Victoria Wang Xiangning Bu
Special Coverage
Blog
Dec 16, 2024, 08:20
Francisco J. Esteva: Addressing gaps in real-world oncology care through data studies
Insight
Dec 16, 2024, 08:08
Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH
Blog
Dec 16, 2024, 08:02
Roupen Odabashian: Revolutionizing healthcare with AI insights from Dyania Health
Blog
Dec 16, 2024, 07:54
Raya Poghosyan: Looking for remote medical transcriptionist opportunities
Blog
Dec 16, 2024, 07:49
The 2025 National Congress is coming to Rome - AIEOP
Blog
Dec 16, 2024, 07:42
Dr. Daniel Anaya appointed as Chair of GI Surgical Oncology - Moffitt Cancer Center
Blog
Dec 16, 2024, 07:33
Sahar Mansour: First Time at OncoEgypt Conference: A Remarkable Experience
Blog
Dec 16, 2024, 07:22
Discover a platform dedicated to HPV and related cancers - HPV World
Blog
Dec 16, 2024, 07:15
Thor Halfdanarson: Struggling with response assessment in patients with NETs?
Dialogues
Dec 16, 2024, 04:44
ASCO24 Updates: Rongbo Lin on M701 for Ascites in Cancer
Dialogues
Dec 16, 2024, 04:39
Beyond the Cancer Diagnosis: Dialogue with Alicia Zhou, Hosted by Adrian Pogacian
Insight
Dec 16, 2024, 04:34
Jacobio Pharma Presented Preliminary Results from a Phase I Trial of Jab-8263 at ASH 2024